Urea Breath Segment and Laboratory Test Segment , by Type, to Account for Largest Share in Helicobacter Pylori (H. pylori) Non-Invasive Testing Market During 2022-2028

According to our latest study on "Helicobacter Pylori (H. pylori) Non-Invasive Testing Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Test Type, Test Method, and End User," the market is expected to grow from US$ 596.82 million in 2021 to US$ 800.04 million by 2028; it is expected to grow at a CAGR of 4.4% from 2022 to 2028. The report highlights the key factors driving the market growth and prominent players with their developments in the market.

Need for Non-invasive Tests due to Rise in H. pylori Infection Cases The rise in prevalence of H. pylori is one of the major reasons driving the Helicobacter Pylori (H. pylori) non-invasive testing market growth. Further, studies have shown that ~50% of the world's population is infected by H. pylori infection. The Infection is usually developed during infancy but remains asymptomatic, with long-standing clinical symptoms including gastritis, peptic ulcer disease, and stomach cancer. Furthermore, the prevalence of the the gastric disease is significantly higher in the geriatric population as aging increases the risk of H. pylori infection. According to World Health Organization (WHO), the population percentage aged 60 years and above is expected to be 13.7% globally and 20.3% in the south-east Asia region by 2030. Aging leads to thinning of the stomach lining, thus allowing the bacteria to pass through the protective lining that contributes to the growing prevalence of Infection among older people.

The Helicobacter Pylori (H. pylori) non-invasive testing market has substantial growth amid the COVID-19 pandemic. For example, breath tests are simple, non-invasive alternatives and are considered harmless for diagnosing H. pylori infection, small intestinal bacterial overgrowth (SIBO), lactose intolerance, and inflammatory bowel disease in North America. Such factors are responsible for the stagnant growth of the market during the forecast period.

Based on test type, the global H. pylori non-invasive testing diagnostics market is segmented into serology, stool antigen, and urea breath. In 2021, the urea breath segment held the largest share of the market test. In addition, owing to growing availability, the urea breath is expected to grow at the fastest rate and will hold a major market share in the forecasted year. Based on test method, the market is bifurcated into laboratory based and point of care. The laboratory based segment held a larger market share in 2021 and is likely to continue its dominance during the forecast period. Based on end user, the market is segmented into clinics, hospitals, diagnostic laboratories, and hospitals. The diagnostic laboratories segment held the largest market share in 2021 and will likely continue its dominance during the forecast period.

DiaSorin S.p.A.; Meridian Bioscience, Inc.; Exalenz Bioscience Ltd.; Alere; Thermo Fisher Scientific; Biomerica, Inc.,; Abbott; and CerTest Biotec are among the leading companies operating in the global Helicobacter Pylori (H. pylori) non-invasive testing market.

Based on geography, the global Helicobacter Pylori (H. pylori) non-invasive testing market is primarily segmented into North America, Europe, Asia Pacific, Middle East & Africa (MEA), and South & Central America. The North America Helicobacter Pylori (H. pylori) non-invasive testing market is further segmented into the US, Canada, and Mexico. The Europe Helicobacter Pylori (H. pylori) non-invasive testing market is subsegmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The Asia Pacific Helicobacter Pylori (H. pylori) non-invasive testing market is subsegmented into China, Japan, India, Australia, South Korea, and the Rest of APAC. The Helicobacter Pylori (H. pylori) non-invasive testing market in the MEA is further segmented into South Africa, Saudi Arabia, the UAE, and the Rest of MEA. The South & Central America Helicobacter Pylori (H. pylori) non-invasive testing market is subsegmented into Brazil, Argentina, and the Rest of South & Central America.

Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@premiummarketinsights.com